Quantum-Si (QSI) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
1 Apr, 2026Voting matters and shareholder proposals
Shareholders will vote to elect ten directors for one-year terms expiring in 2027.
Proposal to ratify PricewaterhouseCoopers LLP as independent auditor for fiscal year ending December 31, 2026.
Advisory vote on executive compensation for named executive officers is included.
Board recommends voting in favor of all proposals and nominees.
Other business may be addressed if properly brought before the meeting.
Board of directors and corporate governance
Ten director nominees are listed, each recommended for election to serve until 2027.
Executive compensation and say-on-pay
Advisory, non-binding vote on executive compensation for named executive officers is on the agenda.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Quantum-Si
- Proteus launch delayed to Q2 2027; cost cuts and $169.9M cash extend runway into Q4 2028.QSI
Q2 2026 - Proteus launches in late 2024, offering scalable, extensible protein sequencing and robust PTM detection.QSI
H.C. Wainwright 4th Annual BioConnect Investor Conference - Proteus milestones reached as revenue fell and cash reserves support operations into 2028.QSI
Q1 2026 - Director elections, auditor ratification, and executive pay are up for vote at a virtual annual meeting.QSI
Proxy filing - 2026 emphasizes consumables growth and Proteus launch, with strong cash reserves and cost control.QSI
Q4 2025 - Automated protein sequencing platform drives adoption and innovation across research sectors.QSI
H.C. Wainwright 26th Annual Global Investment Conference - Rapid innovation and commercial expansion position the platform for strong growth in proteomics.QSI
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024 - Q2 2024 revenue rose 203% to $622,000, with a 57% margin and cash runway into 2026.QSI
Q2 2024 - 183% revenue growth, $86M raised, and cash runway into H2 2027 support strong 2025 outlook.QSI
Q4 2024